- Home
- GSIW vs EVOK Comparison
GSIW vs EVOK Comparison
Compare GSIW & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GSIW | EVOK |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6M | 18.4M |
| IPO Year | 2023 | 2013 |
Fundamental Metrics
Financial Performance| Metric | GSIW | EVOK |
|---|---|---|
| Price | $0.13 | $11.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 342.2K | 30.8K |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,368,221.00 | ★ $14,424,652.00 |
| Revenue This Year | N/A | $58.96 |
| Revenue Next Year | N/A | $57.99 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 283.23 | 67.40 |
| 52 Week Low | $0.09 | $1.94 |
| 52 Week High | $1.79 | $11.00 |
Technical Indicators
Market Signals| Indicator | GSIW | EVOK |
|---|---|---|
| Relative Strength Index (RSI) | 39.31 | 85.30 |
| Support Level | $0.13 | $10.66 |
| Resistance Level | $0.14 | $10.99 |
| Average True Range (ATR) | 0.01 | 0.04 |
| MACD | -0.00 | -0.18 |
| Stochastic Oscillator | 18.97 | 100.00 |
Price Performance
Historical ComparisonAbout GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.